Sorafenib
- OralSorafenibNexavar
Mechanism of Action
- Inhibits multiple receptor tyrosine kinases involved in tumour growth, angiogenesis and metastasis.
Pharmacology
- Many off-target effects due to inhibition of multiple targets.
Clinical Use
- Indications
- Hepatocellular carcinoma
- Renal cell carcinoma
- Differentiated Thyroid cancer
- Adverse Effects
- Fatigue
- Anorexia
- Mucositis
- Diarrhoea (particularly pazopanib)
- Hand-foot syndrome (sunitinib)
- Cardiotoxicity - CCF, MI, thromboembolism, hypertension
- Hypothyroidism